Determination of Sitagliptin with Fluorescamine in Tablets and Spiked Serum Samples by Spectrofluorimetry and a Degradation Study

Caglar S., Onal A., Toker S.

CURRENT PHARMACEUTICAL ANALYSIS, cilt.8, sa.3, ss.278-285, 2012 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 8 Sayı: 3
  • Basım Tarihi: 2012
  • Doi Numarası: 10.2174/157341212801619270
  • Dergi Adı: CURRENT PHARMACEUTICAL ANALYSIS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.278-285
  • İstanbul Üniversitesi Adresli: Evet

Özet

Two novel, simple and rapid stability-indicating spectrofluorimetric methods have been developed for the determination of sitagliptin in tablets and spiked serum samples. In the first method, sitagliptin`s natural fluorescence was measured at 353 nm after excitation at 259 nm. On the basis of the reaction between sitagliptin and fluorescamine the second method has been developed in borate buffer solution of pH 9.0 and the fluorescence intensities of the derivatives were measured at 475 nm emission and 390 nm excitation wavelengths. Thecalibration curves were constructed in concentration range of 0.5-10.0 mu g mL(-1) and 0.2-1.4 mu g mL(-1) for the first and second method, respectively. The developed methods were validated with respect to linearity, precision, sensitivity, accuracy and selectivity. The degradation behaviour of the drug was investigated using the first method. The drug solution was subjected to neutral, acid and alkali hydrolysis, oxidation, thermal stress and exposured to the sunlight. The first method is proved to be selective and useful for the investigation of the stability of sitagliptin. The application of spiked serum samples was also analysed by using the second method. The developed methods were successfully applied for the determination of sitagliptin in tablets and spiked serum samples.
Determination of Sitagliptin with Fluorescamine in Tablets and Spiked Serum Samples by Spectrofluorimetry and a Degradation Study
Author(s): Caglar, S (Caglar, Sena)[ 1 ] ; Onal, A (Onal, Armagan)[ 1 ] ; Toker, S (Toker, Sidika)[ 1 ]
Source: CURRENT PHARMACEUTICAL ANALYSIS  Volume: 8   Issue: 3   Pages: 278-285   Published: SEP 2012
Times Cited: 0 (from Web of Science)
Cited References: 17      [ view related records ]     Citation MapCitation Map     
Abstract: Two novel, simple and rapid stability-indicating spectrofluorimetric methods have been developed for the determination of sitagliptin in tablets and spiked serum samples. In the first method, sitagliptin`s natural fluorescence was measured at 353 nm after excitation at 259 nm. On the basis of the reaction between sitagliptin and fluorescamine the second method has been developed in borate buffer solution of pH 9.0 and the fluorescence intensities of the derivatives were measured at 475 nm emission and 390 nm excitation wavelengths. Thecalibration curves were constructed in concentration range of 0.5-10.0 mu g mL(-1) and 0.2-1.4 mu g mL(-1) for the first and second method, respectively. The developed methods were validated with respect to linearity, precision, sensitivity, accuracy and selectivity. The degradation behaviour of the drug was investigated using the first method. The drug solution was subjected to neutral, acid and alkali hydrolysis, oxidation, thermal stress and exposured to the sunlight. The first method is proved to be selective and useful for the investigation of the stability of sitagliptin. The application of spiked serum samples was also analysed by using the second method. The developed methods were successfully applied for the determination of sitagliptin in tablets and spiked serum samples.
Accession Number: WOS:000307962800008